A carregar...
IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib
A signaling pathway that is frequently deregulated in human carcinomas and has been explored as a therapeutic target involves the activation of the epidermal growth factor receptor (EGFR). Inhibition of EGFR via the small molecule inhibitors erlotinib and gefitinib commonly results in tumor resistan...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5173114/ https://ncbi.nlm.nih.gov/pubmed/27248176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9662 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|